Market Overview:
The global emphysema treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of emphysema, rising awareness about available treatments, and technological advancements in the field of emphysema treatment. The global emphysema treatment market is segmented on the basis of type into centrilobular emphysema and panlobular emphysema. On the basis of application, the market is segmented into hospitals, clinics, and surgical centers. The North America region dominates the global Emphysema Treatment Market followed by Europe due to high prevalence rate for COPD patients in these regions coupled with increasing geriatric population base which are more susceptible to develop COPD symptoms over time.
Product Definition:
Emphysema Treatment is the process of managing and preventing the symptoms of emphysema. Emphysema is a long-term, progressive lung disease that causes difficulty breathing. Emphysema Treatment may include medications to open airways and improve breathing, oxygen therapy, and pulmonary rehabilitation. The importance of Emphysema Treatment is to help people with emphysema breathe easier and live longer.
Centrilobular emphysema:
Centrilobular emphysema also called as central airway obstruction or CABO is a rare type of chronic obstructive pulmonary disease. It is characterized by the formation of numerous small nodules in the center of the lungs. These nodules are known as centrilobes and they grow at a very slow rate compared to other lung tissues.
Panlobular emphysema:
The panlobular emphysema is a rare disease that occurs when the lungs fill with air. It is also known as “Pan lung disorder” or “Silent pulmonary hypertension”. This condition has no symptoms and can only be diagnosed by X-ray tests.
Application Insights:
Based on application, the global emphysema treatment market is segmented into hospital, clinics and surgical center. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a large patient base with advanced disease symptoms. In addition, this segment is expected to maintain its dominance over the forecast period due to increasing prevalence of emphysema across all age groups globally.
The clinics segment is expected to witness significant growth during the forecast period owing to an increase in demand for early diagnosis and effective management of COPD as well as EmPHEDS among other factors such as rising healthcare awareness among population & growing preference for outpatient treatment.
Regional Analysis:
North America dominated the global emphysema treatment market in 2016 with a revenue share of over 45%. The region is expected to maintain its position during the forecast period. This can be attributed to high government funding for R&D, higher healthcare expenditure as well as better reimbursement scenario in this region. In addition, rising prevalence of chronic respiratory diseases and smoking-related illnesses are also contributing toward regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and growing patient awareness about available treatments & their benefits. Moreover, increasing disposable income levels coupled with rising medical tourism in emerging economies such as India & China are further expected boost regional demand during the estimated time span.
Growth Factors:
- Increasing prevalence of emphysema
- Growing awareness about the benefits of emphysema treatment
- Rising demand for minimally invasive procedures for emphysema treatment
- Technological advancements in emphysema treatment procedures
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Emphysema Treatment Market Research Report
By Type
Centrilobular emphysema, Panlobular emphysema
By Application
Hospital, Clinics, Surgical center
By Companies
Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, Emphasys Medical, Pfizer, Olympus, BTG, PneumRx and Uptake Medical, Halozyme Therapeutics, Mariposa Health, Uptake Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Emphysema Treatment Market Report Segments:
The global Emphysema Treatment market is segmented on the basis of:
Types
Centrilobular emphysema, Panlobular emphysema
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Surgical center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pulmonx
- Bioxyne
- Intrexon
- Icure Pharmaceuticals
- Kamada
- Emphasys Medical
- Pfizer
- Olympus
- BTG
- PneumRx and Uptake Medical
- Halozyme Therapeutics
- Mariposa Health
- Uptake Medical
Highlights of The Emphysema Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Centrilobular emphysema
- Panlobular emphysema
- By Application:
- Hospital
- Clinics
- Surgical center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Emphysema Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for emphysema will vary depending on the individual's symptoms and medical history. However, some common treatments for emphysema include:nnu2022 Smoking cessation therapy: This is one of the most important treatments for emphysema, as quitting smoking can significantly improve your health overall and reduce your risk of developing lung cancer.nnu2022 Medications: Many people with emphysema are prescribed medications to help them breathe more easily. These medications may include bronchodilators (drugs that open up air passages), antihistamines (medicines used to treat allergies), or steroids (drugs used to treat conditions like asthma).
Some of the major companies in the emphysema treatment market are Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, Emphasys Medical, Pfizer, Olympus, BTG, PneumRx and Uptake Medical, Halozyme Therapeutics, Mariposa Health, Uptake Medical.
The emphysema treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Emphysema Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Emphysema Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Emphysema Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Emphysema Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Emphysema Treatment Market Size & Forecast, 2018-2028
4.5.1 Emphysema Treatment Market Size and Y-o-Y Growth
4.5.2 Emphysema Treatment Market Absolute $ Opportunity
Chapter 5 Global Emphysema Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Emphysema Treatment Market Size Forecast by Type
5.2.1 Centrilobular emphysema
5.2.2 Panlobular emphysema
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Emphysema Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Emphysema Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Surgical center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Emphysema Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Emphysema Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Emphysema Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Emphysema Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Emphysema Treatment Market Size Forecast by Type
9.6.1 Centrilobular emphysema
9.6.2 Panlobular emphysema
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Emphysema Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Surgical center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Emphysema Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Emphysema Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Emphysema Treatment Market Size Forecast by Type
10.6.1 Centrilobular emphysema
10.6.2 Panlobular emphysema
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Emphysema Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Surgical center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Emphysema Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Emphysema Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Emphysema Treatment Market Size Forecast by Type
11.6.1 Centrilobular emphysema
11.6.2 Panlobular emphysema
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Emphysema Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Surgical center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Emphysema Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Emphysema Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Emphysema Treatment Market Size Forecast by Type
12.6.1 Centrilobular emphysema
12.6.2 Panlobular emphysema
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Emphysema Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Surgical center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Emphysema Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Type
13.6.1 Centrilobular emphysema
13.6.2 Panlobular emphysema
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Surgical center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Emphysema Treatment Market: Competitive Dashboard
14.2 Global Emphysema Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pulmonx
14.3.2 Bioxyne
14.3.3 Intrexon
14.3.4 Icure Pharmaceuticals
14.3.5 Kamada
14.3.6 Emphasys Medical
14.3.7 Pfizer
14.3.8 Olympus
14.3.9 BTG
14.3.10 PneumRx and Uptake Medical
14.3.11 Halozyme Therapeutics
14.3.12 Mariposa Health
14.3.13 Uptake Medical
